El 50% de los pacientes con este tipo de tumor sufre recaídas, lo que reduce significativamente sus opciones terapéuticas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback